2. New Targeted Therapies for CLL

Publisher： Nova Science Publishers, Inc.

ISSN： 1554-1134

Source： International Journal of Cancer Research and Prevention, Vol., Iss., 2017-01, pp. : 69-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Antibody–drug conjugates (ADCs)—new targeted therapies

By Papakonstantinou Georgios  

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 223-224

Springer Publishing Company

Access to resources Recommend Favorite

New Targeted Therapies for Anaplastic Thyroid Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 1, 2012-01 ,pp. : 87-93

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapies in bronchioloalveolar carcinoma

By Scagliotti Giorgio  

Targeted Oncology, Vol. 3, Iss. 3, 2008-07 ,pp. : 197-204

Springer Publishing Company

Access to resources Recommend Favorite

Cell-cycle targeted therapies

By Swanton C.  

Lancet Oncology, Vol. 5, Iss. 1, 2004-01 ,pp. : 27-36

Elsevier

Access to resources Recommend Favorite

New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 4, 2015-05 ,pp. : 461-467

Bentham Science Publishers

Access to resources Recommend Favorite